microRNA-618表达与系统性硬化症患者浆细胞样树突状细胞频率及活化改变相关
该研究在3个独立队列的健康对照和系统性硬化症(SSc)患者外周血高纯度浆细胞样树突状细胞(PDC)中进行miRNA表达谱分析和验证,发现SSc患者PDC中miR-618表达上调,且IFN调节因子8是其靶点。miR-618过表达可减少CD34+细胞体外分化为PDC并增强其分泌IFNα的能力,模拟SSc患者PDC表型。
要点
- SSc患者PDC中miR-618表达上调,包括无皮肤纤维化的早期患者。
- IFN调节因子8被鉴定为miR-618的靶点。
- miR-618过表达减少PDC发育并增强IFNα分泌,模拟SSc表型。
核心结论
- miR-618上调抑制PDC发育并增强其分泌IFNα的能力,可能促成SSc患者中观察到的I型IFN特征。
研究设计与样本
- 在3个独立队列的健康对照和SSc患者外周血高纯度PDC中进行miRNA表达谱分析和验证,并通过在健康PDC中过表达miR-618探究其功能。
主要发现
- SSc患者PDC中miR-618表达上调,包括无皮肤纤维化的早期疾病患者。
- IFN调节因子8被鉴定为miR-618的靶点。
- miR-618过表达减少CD34+细胞体外分化为PDC并增强其分泌IFNα的能力,模拟SSc患者PDC表型。
临床怎么用
- miR-618可能作为调控I型IFN特征的 epigenet ic 靶点,用于SSc等以I型IFN特征为特点的疾病中调节免疫稳态。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: Plasmacytoid dendritic cells (PDCs) are a critical source of type I interferons (IFNs) that can contribute to the onset and maintenance of autoimmunity. Molecular mechanisms leading to PDC dysregulation and a persistent type I IFN signature are largely unexplored, especially in patients with systemic sclerosis (SSc), a disease in which PDCs infiltrate fibrotic skin lesions and produce higher levels of IFNα than those in healthy controls. This study was undertaken to investigate potential microRNA (miRNA)-mediated epigenetic mechanisms underlying PDC dysregulation and type I IFN production in SSc. METHODS: We performed miRNA expression profiling and validation in highly purified PDCs obtained from the peripheral blood of 3 independent cohorts of healthy controls and SSc patients. Possible functions of miRNA-618 (miR-618) on PDC biology were identified by overexpression in healthy PDCs. RESULTS: Expression of miR-618 was up-regulated in PDCs from SSc patients, including those with early disease who did not present with skin fibrosis. IFN regulatory factor 8, a crucial transcription factor for PDC development and activation, was identified as a target of miR-618. Overexpression of miR-618 reduced the development of PDCs from CD34+ cells in vitro and enhanced their ability to secrete IFNα, mimicking the PDC phenotype observed in SSc patients. CONCLUSION: Up-regulation of miR-618 suppresses the development of PDCs and increases their ability to secrete IFNα, potentially contributing to the type I IFN signature observed in SSc patients. Considering the importance of PDCs in the pathogenesis of SSc and other diseases characterized by a type I IFN signature, miR-618 potentially represents an important epigenetic target to regulate immune system homeostasis in these conditions.
引用
- Rossato M, Affandi AJ, Thordardottir S, et al. Association of MicroRNA-618 Expression With Altered Frequency and Activation of Plasmacytoid Dendritic Cells in Patients With Systemic Sclerosis. Arthritis Rheumatol. 2017. PMID: 28556560. doi:10.1002/art.40163
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。